Predict your next investment

Sante company logo
Venture Capital
FINANCE | Investment Firms & Funds
sante.com

See what CB Insights has to offer

Investments

82

Portfolio Exits

13

Funds

7

Service Providers

1

About Sante

Sante is a life sciences venture capital firm that invests exclusively in early-stage companies developing new medical technologies or healthcare delivery models. The firm was founded in 2006.

Sante Headquarter Location

201 W 5th St Suite 1500

Austin, Texas, 78701,

United States

512-721-1200

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Sante

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Sante in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

10,294 items

Sante Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Sante Rank

Latest Sante News

Five Arrows exits pharmacy group Laf Sante to Latour

Jul 13, 2022

8h agoPrivate EquityunquoteViews: 10 Five Arrows has sold Hygie31, a France-based pharmacy chain that includes low-cost brand Laf Sante, to Latour Capital in an auction preempted by the French sponsor. Not a member yet? Free Membership for Qualified Investors and Industry Participants Easily Customize Content to Match Your Investment Preferences Breaking News 24/7/365 Alternative Investment Listings & LeaderBoards Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets,Presentations, Investment Mandates, Video PitchBooks & More! Company Directory AUM Accelerator Program (designed for investment managers) Over 450K+ Industry Headlines, Posts and Updates ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY.CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN.PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.THIS IS NOT A SOLICITATION FOR INVESTMENT.THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY.IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES.ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM.PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT. ALPHAMAVEN

Sante Investments

82 Investments

Sante has made 82 investments. Their latest investment was in Endovascular Engineering as part of their Series A - II on April 4, 2022.

CBI Logo

Sante Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/5/2022

Series A - II

Endovascular Engineering

$15M

Yes

2

3/24/2022

Series A - III

Geneos Therapeutics

$17M

No

9

1/26/2022

Series A - II

Reimagine Care

$18.75M

Yes

6

1/11/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

10/26/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/5/2022

3/24/2022

1/26/2022

1/11/2022

10/26/2021

Round

Series A - II

Series A - III

Series A - II

Series A

Series A

Company

Endovascular Engineering

Geneos Therapeutics

Reimagine Care

Subscribe to see more

Subscribe to see more

Amount

$15M

$17M

$18.75M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

9

6

10

10

Sante Portfolio Exits

13 Portfolio Exits

Sante has 13 portfolio exits. Their latest portfolio exit was Farapulse on June 24, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/24/2021

Acquired

$99M

16

9/30/2019

Reverse Merger

$99M

2

12/27/2018

Acquired

$99M

2

7/20/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

7/9/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/24/2021

9/30/2019

12/27/2018

7/20/2018

7/9/2018

Exit

Acquired

Reverse Merger

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

16

2

2

10

10

Sante Fund History

7 Fund Histories

Sante has 7 funds, including Sante Health Ventures IV.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/16/2021

Sante Health Ventures IV

$260M

4

5/29/2019

Sante Health Ventures III

Subscribe to see more

Subscribe to see more

$99M

10

4/5/2019

Gateway VCA 0319

$99M

10

4/11/2014

Sante Health Ventures II

Subscribe to see more

Subscribe to see more

$99M

10

4/17/2008

Sante Health Ventures

$99M

10

Closing Date

9/16/2021

5/29/2019

4/5/2019

4/11/2014

4/17/2008

Fund

Sante Health Ventures IV

Sante Health Ventures III

Gateway VCA 0319

Sante Health Ventures II

Sante Health Ventures

Fund Type

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Amount

$260M

$99M

$99M

$99M

$99M

Sources

4

10

10

10

10

Sante Service Providers

1 Service Provider

Sante has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

General Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

Sante Team

9 Team Members

Sante has 9 team members, including current Chief Operating Officer, Steven E Seach.

Name

Work History

Title

Status

Steven E Seach

Chief Operating Officer

Current

Joe Cunningham

Managing Director

Current

Joe Cunningham

Managing Director

Current

James Eadie

U.S. Air Force

Managing Director

Current

Douglas D. French

Managing Director

Current

Name

Steven E Seach

Joe Cunningham

Joe Cunningham

James Eadie

Douglas D. French

Work History

U.S. Air Force

Title

Chief Operating Officer

Managing Director

Managing Director

Managing Director

Managing Director

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.